Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Cancer Research and Treatments, and Cancer, Hypoxia, and Metabolism.
Murine gut microbiota dysbiosis via enteric infection modulates the foreign body response to a distal biomaterial implant
Murine gut microbiota dysbiosis via enteric infection modulates the foreign body response to a distal biomaterial implant
Transfer learning in a biomaterial fibrosis model identifies in vivo senescence heterogeneity and contributions to vascularization and matrix production across species and diverse pathologies
Human Colon Cancer–Derived <i>Clostridioides difficile</i> Strains Drive Colonic Tumorigenesis in Mice
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis
Interleukin 17 and senescent cells regulate the foreign body response to synthetic material implants in mice and humans
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Interleukin-36γ–producing macrophages drive IL-17–mediated fibrosis
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer
Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells
The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity
Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells
mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3+ Regulatory T Cells
Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment
Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8+ T cell differentiation
The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis
Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis
Generation of MANAbodies specific to HLA-restricted epitopes encoded by somatically mutated genes
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients